
Bioorganic and Medicinal Chemistry Letters p. 1649 - 1654 (1998)
Update date:2022-08-03
Topics:
Hoekstra, William J.
Hulshizer, Becky L.
McComsey, David F.
Andrade-Gordon, Patricia
Kauffman, Jack A.
Addo, Michael F.
Oksenberg, Donna
Scarborough, Robert M.
Maryanoff, Bruce E.
The thrombin receptor (PAR-1) is activated by α-thrombin to stimulate various cell types, including platelets, through the tethered-ligand sequence SFLLRN. A series of azole-based carboxamides, designed after SFLLR, were synthesized and evaluated in vitro. The compounds inhibited platelet aggregation induced by SFLLRN-NH2 or α-thrombin, and blocked the binding of [3H]-S-(p-F-Phe)-Har-L-Har-KY-NH2 to a CHRF membrane preparation of PAR-1. Oxazole 30 bound to PAR-1 with an IC50 of 1.6 μM, and gave IC50 values of 25 μM and 6.6 μM against α-thrombin- and SFLLRN-NH2-induced platelet aggregation, respectively.
View MoreRongCheng K&S Chemical Co.,Ltd
Contact:0631-7336369
Address:rongcheng ,shandong province china
Tianjin Pharmacn Medical Technology Co.,Ltd.
Contact:86-22-60122566ext.866(English),23359620
Address:Green Industrial Base, 6 Haitaifazhan Sixth Rd., Huayuan Industrial Area, Tianjin, 300384, China
Chengdu Gelipu Biotechnology Co., Ltd.
website:http://www.glp-china.com
Contact:86-28-82610909
Address:chegndu
Contact:
Address:
Contact:+86-10-59484199
Address:No.58-A1026 Liangguan Street
Doi:10.1134/S0022476611030280
(2011)Doi:10.1246/cl.1980.425
(1980)Doi:10.1021/acs.joc.0c00279
(2020)Doi:10.1021/jm00131a012
(1989)Doi:10.1080/10426500802705537
(2009)Doi:10.1016/j.saa.2009.11.022
(2010)